Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1994-6-27
|
pubmed:abstractText |
We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin alpha 1 (T alpha 1) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/K12 cells (1,2-dimethylhydrazine-induced colon adenocarcinoma) in syngeneic BDIX rats. The presence of liver metastases was checked by laparotomy 14 days after tumor-cell injection. Evaluable rats were assigned randomly to 5 experimental groups designated as control, 5-FU, IL-2, 5-FU/IL-2 and 5-FU/T alpha 1/IL-2. 5-FU was administered i.v. as a continuous infusion for 7 days by an osmotic device implanted surgically. T alpha 1 and IL-2 were administered for 4 days and repeated after 11 days. Combined chemo-immunotherapy was shown both to significantly reduce the growth of liver metastases and to prevent extra-hepatic spread. 5-FU/T alpha 1/IL-2 also improved survival rate. Combined immunotherapy after 5-FU restored NK activity of the peripheral-blood-mononuclear-cell (PBMC) in tumor and/or 5-FU immunodepressed rats and enhanced PBMC cytotoxic activity against the DHD/K12 autologous cell line. This model was devised to mimic the clinical situation of unresectable liver metastases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
701-5
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:8194879-Animals,
pubmed-meshheading:8194879-Carcinoma,
pubmed-meshheading:8194879-Colorectal Neoplasms,
pubmed-meshheading:8194879-Combined Modality Therapy,
pubmed-meshheading:8194879-Cytotoxicity, Immunologic,
pubmed-meshheading:8194879-Fluorouracil,
pubmed-meshheading:8194879-Immunotherapy,
pubmed-meshheading:8194879-Interleukin-2,
pubmed-meshheading:8194879-Killer Cells, Natural,
pubmed-meshheading:8194879-Liver Neoplasms,
pubmed-meshheading:8194879-Male,
pubmed-meshheading:8194879-Rats,
pubmed-meshheading:8194879-Rats, Inbred Strains,
pubmed-meshheading:8194879-Survival Analysis,
pubmed-meshheading:8194879-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:8194879-Thymosin
|
pubmed:year |
1994
|
pubmed:articleTitle |
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.
|
pubmed:affiliation |
Istituto di Medicina Sperimentale, Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|